My reading of that report is that post Phase 1 the target is 4 x (ie $2) and post Phase 2 the target is over $7.
Both price targets assume success at each Phase and depending on continued pace of trials the $7 target may be end of 2023.
Ann: SRC Approves Commencement Of Fourth And Final Cohort Dosing, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
83.0¢ |
Change
-0.015(1.78%) |
Mkt cap ! $105.5M | |||
| Open | High | Low | Value | Volume |
| 86.3¢ | 88.0¢ | 81.5¢ | $191.9K | 225.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6895 | 83.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 86.5¢ | 137 | 1 |
View Market Depth
| Last trade - 15.59pm 16/08/2024 (20 minute delay) ? |
| AGN (ASX) Chart |